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Objectives: This article seeks to review and discuss the evidence linking depression, coronary 
heart disease (CHD) and culture.  
Methods: PsychInfo, CINAHL and Pub med were searched for articles publishing evidence 
related to depression, culture and CHD and interrelations between these concepts. Retrieved 
articles were analyzed using narrative review and thematic content analysis. 
Results: Key themes identified from the literature review were: 1) Depression is a factor in 
development and prognosis of CHD and impacts on the capacity to self-manage and adhere to 
treatment recommendations; 2) Culture mediates mental health/illness representations and 
treatment seeking behaviors and may further hinder detection and treatment of depression in 
cardiac patients; and 3) There is a need for culturally appropriate screening and therapeutic 
strategies.  
Conclusions: Management of depression in individuals from diverse cultures requires using 
linguistically and culturally competent strategies to ensure accurate screening and detection of 
depressive symptoms and if applicable, offering a type of treatment that is acceptable and more 
likely to be adhered to by the patient. 
Practice implications: As depression is a predictor and moderating variable in the genesis and 
progression of CHD, understanding how factors, such as culture impact on screening and 
management is important for clinical practice. 





Physical health is an important underpinning to mental wellbeing and these links are 
bidirectional [1]. Depression is a common co-morbid condition of many chronic diseases 
including coronary heart disease (CHD) [2]. Patients following an acute cardiac event have 
nearly 3-fold higher risk of developing depressive symptoms compared with the general 
population, and the prevalence is similar in patients with diverse range of cardiac conditions [3], 
with slightly higher rates in patients with heart failure [4]. An extensive literature consistently 
associates depression with increased risk of both incident CHD and poor prognosis in cardiac 
patients, although between-studies differences exist in design, sample size, screening tools, 
assessment time and follow up period. Despite its high prevalence, impact on cardiovascular 
outcomes and yet cost effective treatability, depression in cardiac patients is unrecognized and 
untreated [3].   
Highlighting the importance of depression in the management of CHD, the American Heart 
Association (AHA) Prevention Committee in 2008 emphasized the need to screen and treat 
depression and recommended all patients with CHD should be screened for depressive 
symptoms. The Committee advocated the Patient Health Questionnaire (PHQ-9) for screening 
and referring patients who need further assessment and/or treatment for depression [3]. Although 
this is an important step towards increasing awareness and screening for depression in patients 
with CHD in general, the science advisory fails to address the issue in linguistically and 
culturally diverse patients and whether PHQ-9 posses psychometric properties of validity, 
reliability, and high sensitivity for detecting depression across cultures. Undoubtedly, culture 
shapes an individual’s perceptions and explanatory models to identify and respond to illness, 
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particularly mental health and part of understanding of the experience of depression depends on 
cultural perceptions of what symptoms become labeled as a depressive disorder and how 
depression is thought of within a particular culture [5]. The representation of depression and the 
process through which individuals admit depression and seek medical care is mainly culturally 
determined [6]. Understanding socio-cultural factors in depression can improve detection of 
depressive symptoms in cardiac patients and the offering a type of treatment that is acceptable 
and more likely to be adhered to by the patient. This article reviews the conceptual and empirical 
issues regarding the interaction of depression, heart disease and culture. Specifically we have 
sought to identify whether depression is a factor in cardiac patients and how culture might affect 
detection and treatment of depression in patients with CHD.  
2. Method:  
Articles were identified by searching PsychInfo, CINAHL and Pub med using various 
combinations of key words “depression”, “coronary heart disease”, “coronary artery disease”, 
“cardiovascular disease” and “culture”, and the identified articles were limited to studies written 
in English. Literature on depression in cardiac patients and the role of culture in development 
and expression of depressive symptoms and help seeking behaviors was reviewed to highlight 
issues in management of depression in culturally and linguistically diverse patients. Retrieved 
articles were analyzed using thematic content analysis [7]. 
3. Results:  
The results of this review will be discussed under the following themes: 1) Depression is an 
important factor in coronary heart disease and impacts on the capacity to self-manage and adhere 
to treatment recommendations; 2) Culture mediates health/ illness representations and treatment 
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seeking behaviors, and may further hinder detection and treatment of depression in cardiac 
patients; 4) there is a need for therapeutic strategies within a framework of culture.  
3.1.  Depression is an important factor in cardiac patients  
Cardiovascular disease is the main cause of mortality and depression the major cause of 
disability worldwide and they are projected to continue to do so for the next couple of decades 
[8]. Development and prognosis of both CHD and depression have been affected by transition 
from conformity to individualism and the association between these two diseases been reported 
globally; however, there seem to be cross cultural differences linking depression to CHD [9]. In 
a large international multicentre survey by the World Health Organization in 1995, the highest 
link between depression and heart disease was found in Santiago in Brazil, in that 50% of 
depressed people reported co morbidity of heart disease and the lowest was reported from 
Nagasaki in Japan (7.2%) [9]. These results may reflect vulnerability of some cultural groups to 
depression in response to physical disease and support the idea that members of different cultures 
experience stressful events quite differently. These differences may be partially explained by 
cultural variations in emotional response to a health threat including heart disease. These 
responses are influenced by causal attributions, labeling the symptoms, the perception of 
temporality and curability, and the ability to control events and the consequences of a health 
threat and influence an individual’s capacity to cope with a health threat [10].  
A systematic reviews of studies to estimate the magnitude of the risk posed by depression for 
onset of coronary disease concluded that depression increases the risk of developing CHD 1/64 
times [11].  In addition, depression, both major and minor, has been linked to an increased risk of 
morbidity and mortality in patients with CHD [3]. These associations do not seem to disappear 
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over the course of long-term follow-ups. With the aim of investigating the long-term risk of 
death in cardiac patients with depression, Barefoot et al. [12] followed 1250 patients with 
established CHD for up to 19.4 years and found that compared with non depressed patients 
cardiac patients with moderate to severe depression had 69% higher risk for cardiac death and 
78% greater risk for all-cause death patients, after adjusting for disease severity and treatment. 
Although the precise mechanism is not completely understood, both biochemical and behavioral 
factors have been shown to influence depression in patients with heart disease. Depression 
increases heart rate and reduces heart rate variability. It is also associated with abnormal platelet 
function and endothelial dysfunction [13]. Further, behavioral effects of depression have been 
reported, with depressed patients being vulnerable to other CHD risk factors, such as smoking, 
failure to exercise and poor patient adherence to medications, attendance at CR and life style 
changes [14]. This is of particular significance considering the importance of adherence to 
treatment regimen and self-management in chronic diseases including heart disease.  
These effects are likely exacerbated in societies where cultural and religious considerations 
already hamper participation- particularly of women- in risk reducing activities such as exercise 
and attendance at cardiac rehabilitation programs (CR), poor patient-doctor communications and 
follow-up consultations exist [15]. This is important considering the fact that women-with or 
without CHD- are at higher risk of developing depression and show lower attendance rate and 
greater drop out from CR than men [16]. Other socio cultural factors such as unemployment and 
social isolation also seem mediates relationship between depression and CHD in women. 
Research suggests that women with established CHD who are employed have lower depression 
symptoms and better social support than women who are unemployed [15]. These findings have 
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an implication that the social inequality and economical disadvantages experienced by women in 
some cultures may affect experience, detection and management of depression in women with 
CHD. These factors may collectively contribute to the poorer clinical CHD outcomes in women, 
such as higher rehospitalisation rates and experience of angina symptoms [17]. 
3.2.   Culture mediates illness representations and help seeking behaviors  
Culture and ethnicity are important features of health and illness, in that health-risk life styles, 
illness representation, help-seeking behaviors and compliance with medical advice are all 
reflections of an individual’s cultural norms, values and experiences and need to be integrated 
into an individual’s health care [18, 19].  In response to an increasing recognition of the role of 
cultural context and perceptions in shaping an individual's health and outcomes ethno medicine 
have been developed and evolving to better understand socio-cultural factors important in 
disease management. Cultural factors affecting disease development and prognosis, the process 
of symptom recognition and illness representation as well as the receptivity to treatment 
modalities are thus of interest to Ethno medicine [20].   
Although depression disease is a global health concern, significant cross-cultural variations exit 
in how depression illness is expressed and coped with. Kleinman et al [21] argue that while 
depression disease is conceived as malfunctioning of bio-psycho-physiologic processes in 
individuals, depressive illness represents personal, interpersonal and cultural response to 
depression, meaning that depressive illness is specific and culturally constructed. Cultural factors 
profoundly influence the way an individual conceptualizes, experiences and present depression. 
Further, help seeking behaviors for depression are influenced by cultural norms and values. For 
example, although somatic symptoms of depression are not uncommon worldwide, people from 
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non-Western cultures such as Chinese, Japanese are more likely to present with strictly somatic 
symptoms of depression  [22, 23]. In many non-Western cultures such as Japan, china and 
Middle East, people try to deny depression for fear of being stigmatized as mentally ill and are 
more comfortable to present physical symptoms of depression [24]. In other words, culture 
determines the degree to which a particular individual shows somatic symptoms of depression 
such as fatigue and pain. These cultural variations in clinical presentation may hinder diagnosis 
of depression resulting in patients not being diagnosed and not receiving appropriate treatment. 
The variations in presentation of depression may partially be related to cultural differences in 
causal attribution to depression; while people from Western cultures generally believe in 
biochemical imbalance, in some cultures mental disease including depression is related to 
supernatural forces [24, 25]. Indians attribute it to heat and cold [26] and Chinese to energy flow 
which is rooted in Buddhism [19]. Patients may attribute depressive symptoms to their cardiac 
disease and believe that they would be temporary in duration and therefore may not be willing to 
discuss these symptoms with their doctor. Patients’ beliefs about causes of their depression often 
dictate the source of help and may hinder help seeking behaviors of depressed cardiac patients 
[27]. Interestingly depression itself seems to affect patients’ casual attributions to cardiac 
disease. In a study by Gholizadeh et al. (2009) patients with severe depression were more likely 
to attribute their heart disease to depression and not to modifiable behavioral risk factors [28], 
adding another barrier to risk factor modification in cardiac patients.   
3.3.   Culture impacts on screening and assessment 
Despite its high prevalence and significant impact on cardiovascular health outcomes, the 
detection and treatment of depression among CHD patients have been suboptimal, partially 
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because these symptoms are viewed as normal and temporary emotional reaction to cardiac 
disease [3]. In addition, detection and management of depression present significant cultural and 
methodological challenges for health professionals and researchers. Cultural factors affect 
disease acceptance and help seeking for depression. Despite worldwide prevalence, there is still 
considerable stigma surrounding mental disease including depression, particularly in developing 
countries. Developed countries have taken initiatives to reduce stigma associated with mental 
health diseases through public education and national mental health campaigns. In the United 
States of America (USA), for example, increasingly people’s attitudes towards mental health 
treatment seeking are becoming positive [29]. However, the enormity of stigma towards 
depression in developing countries is explicit in a study conducted by Ozmen et al. (2004) in 
Turkey. Findings of this study showed that the public’s attitudes towards depression were very 
negative. There was a tendency to isolate depressed patients from the society, with nearly half of 
the subjects perceiving depressed people as dangerous, one-quarter of the subjects stating that 
depressive patients should not be free in the community, and more than half stating that they 
would not rent their house to a person with depression [6].   
Social stigma toward mental disease may prevent individuals from reporting their depressive 
symptoms and affects the accuracy of the statistics reported for prevalence/incidence of 
depression [6]. In societies where social stigma is high, a tendency for somatic presentation of 
depressive symptoms is high, as people may find it easier and more acceptable to discuss the 
somatic symptoms of their disease [22]. Non-specific presentation of depression such as fatigue, 
dizziness, neck pain and insomnia, which are also common in patients with CHD, may 
complicate diagnosis of depressive symptoms in cardiac patients and delay treatment [30]. It is 
not clear, however, whether depressed cardiac patients are subject to stigmatization at the same 
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degree as depressed patients without a physical disease. These patients may experience less 
stigma because of a supposed biological cause-CHD disease- inducing their depression [31].   
Another issue that requires consideration is the validity and responsiveness of depression 
assessment measures used for screening of depression in cardiac patients from diverse language 
and cultural backgrounds. Time and cost constraints are common barriers to the use of the 
diagnostic interview, which is considered as the gold standard for defining clinical depression 
[32]. Therefore, self-reported depression tools continue to maintain their usage in research and 
practice. Examples of frequently used tools in cardiac patients are the Beck Depression Inventory 
(BDI). Cardiac Depression Scale (CDS), Hospital Anxiety and Depression Inventory, Beck 
Depression Inventory-Fast Screen for Medical Patients, Hamilton Depression Rating Scale and 
Centre for the Epidemiological Studies Depression Scale (CESD). Recently, the AHA 
Prevention Committee (2008) recommended the PHQ-9 for screening for depression in cardiac 
patients [3], yet capability of this instrument to correctly and with sensitivity screen for 
depression in culturally diverse patients need to be investigated. Validation of depression 
detection tools against culturally sensitive diagnostic interviews may improve credibility and 
reliability of these measures. 
In addition, the extent to which responses to psychometric measures reflect the true rate of 
depression across cultures remains an issue of concern. It has been shown that there are cultural 
differences in response to rating scales and members of some cultures tend to ignore midpoint of 
a scale items and chose extremes [33, 34]. For example, a study by Lee et al. (2002) found that 
when expressing positive feelings, Japanese and Chinese were more likely to choose the 
midpoint of a Likert scale item than Americans and Japanese were also more likely than 
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Americans to reject negative items [34]. Cross-cultural response bias in response to screening 
tools for depression may lead to a contaminated conclusion about variations in the experience of 
depression in cardiac patients across cultures. 
3.4.   Need for therapeutic strategies within a framework of culture 
Like general population, in patients with CHD the treatment options for depression include 
pharmacotherapy, psychosocial interventions or a combination of both. Sertraline and 
citalopram, the two selective serotonin reuptake inhibitor (SSRI) antidepressants, have been 
shown to be safe and effective for treatment of depression and improving quality of care in 
patients with CHD and are recommended by the AHA Prevention Committee as first-line 
therapies for these patients. Nevertheless, patients should be monitored closely for potential 
adverse effects of antidepressants and medication adherence [3]. Psychosocial interventions such 
as behavioral therapy, cognitive behavior therapy and interpersonal therapy may also be used in 
combination with pharmacotherapy or alone [3].  
Individual preferences and culture are undeniably a critical element to be taken into account in 
treatment of depression. Depressed individuals' preferred resources to seek help are influenced 
by the meaning that they attach to depressive symptoms, disease acceptance as well as 
accessibility of mental health care. Conceptualization of depression symptoms influences 
treatment options across cultures. A study by Karasz (2005) found that South Asian immigrants 
to USA see depressive symptoms as a as social problems or emotional reactions to situations 
such as problem with in-laws than chemical imbalances in the brain and for them treatment 
strategies involve solving the problem or avoiding thinking about the problem [35]. In cultures 
12 
 
where depressive symptoms are rather conceived as “illness” than “disease”, the possibility that 
an individual seeks help from alternative practitioners from their own cultures increases [19]. 
The degree to which antidepressant medications are accepted and adhered to are influenced by 
self- stigma and social stigma towards depression and antidepressants. Further, lack of belief in 
effectiveness of treatment or a perception that antidepressants are addictive may lead to some 
people rejecting antidepressants and preferring alternative practices such as interpersonal 
therapy, herbs, meditation and exercise [6, 19]. For example, Hispanic Americans less than non-
Hispanic whites seek help from mental health specialists and tend to prefer pharmacotherapy in 
combination with counseling to pharmacotherapy alone [36]. Cognitive behavioral therapy has 
been shown can benefit depression in patient with CHD and may be an alternative for patients 
who prefer nonpharmacological treatment [3].  
Treatment of depression may be further overlooked and delayed in cardiac patients from diverse 
linguistic and cultural groups due to factors such as lack of awareness of mental health services, 
communication barriers, and unwillingness to report symptoms of depression and nonspecific 
presentation of depressive symptoms such as somatic presentations [36].    
Further, CR and exercise training programs have been shown to affective in reducing depressive 
symptoms [37]. Management of depression in cardiac patients from diverse language and 
cultural backgrounds requires, at minimum, health professionals to have access to a quality 
translation of a depression screening tool, such as the PHQ-9 in various languages and to be 
equipped with cultural competency skills. Despite the effectiveness of CR, patients from 
minority groups show lower cardiac rehabilitation attendance for many reasons[38]. For 
example, in some cultures a belief that patients should take a passive role and stay in bed [39, 40] 
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may prevent CR attendance which shows benefit in reduction of depression in cardiac patients. 
Thus, culturally competent CR programs have a capacity to increase the attendance rate of 
culturally diverse population groups and help these patients with their depression problem. 
Patients with heart disease may better respond to interventions for reduction of depression that 
imply culturally and linguistically sensitive approaches to describe the cause of depressive 
symptoms and how available treatment modalities could help ease depressive symptoms and 
improve their functionality and quality of life.  
4. Discussion and Conclusion:  
Effectiveness of interventions to improve quality of life, reduce depression and likely improve 
adherence to treatment recommendations suggests that screening for depression and providing an 
appropriate counseling and/or medical treatments should be incorporated into the management of 
CHD to improve clinical outcomes. Patients from minority groups; however, are less likely to 
use these programs, to be actively involved in cardiovascular risk reducing behaviors and adhere 
to recommended medical regimen [41]. Depression co morbidity may further hamper changing 
risky behaviors and medication adherence in this population group.  
Social stigma towards mental disease profoundly influences the conceptualization of depression, 
presentation of the disease and the individual’s acceptance of recommended treatment. Culturally 
and linguistically competent approaches may ensure that cardiac patients from diverse cultural 
groups could also benefit from a wide range of depression treatment modalities including 
pharmacotherapy, psychological counseling, and alternative therapies such as exercise 
rehabilitation. Further, attention should be granted to the validity of depression assessment tools 
when screening and reporting depression in culturally and linguistically diverse populations.  
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Practice Implications: As depression is a predictor and moderating variable in the genesis and 
progression of CHD, understanding how factors, such as culture impact on screening and 
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